HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT
0.0.1 - DRAFT United States of America flag

HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT, published by HL7 International Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/standardhealth/fsh-ae/ and changes regularly. See the Directory of published versions

: medrequest-doxorubicin-persona-2 - XML Representation

Raw xml | Download



<MedicationRequest xmlns="http://hl7.org/fhir">
  <id value="medrequest-doxorubicin-persona-2"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"/>
  </meta>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicationRequest</b><a name="medrequest-doxorubicin-persona-2"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationRequest &quot;medrequest-doxorubicin-persona-2&quot; </p><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/us/mcode/2021May/StructureDefinition-mcode-cancer-related-medication-request.html">Cancer-Related Medication Request</a></p></div><p><b>Treatment Intent</b>: Curative - procedure intent (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#373808002)</span></p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>category</b>: Outpatient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-medicationrequest-category.html">MedicationRequest Category Codes</a>#outpatient)</span></p><p><b>medication</b>: DOXOrubicin <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#3639)</span></p><p><b>subject</b>: <a href="Patient-PatientPersona2.html">Patient/PatientPersona2</a> &quot; C.&quot;</p><p><b>authoredOn</b>: 2020-10-06</p><p><b>requester</b>: <a href="Practitioner-us-core-practitioner-owen-oncologist.html">Practitioner/us-core-practitioner-owen-oncologist</a> &quot; ONCOLOGIST&quot;</p><p><b>reasonReference</b>: <a href="Condition-primary-cancer-condition-persona-2.html">Condition/primary-cancer-condition-persona-2</a></p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: doxorubicin (60 mg/m² IV)</p><p><b>timing</b>: Starting 2018-04-01, Once</p><p><b>route</b>: Intravenous route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#47625008)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote><p><b>maxDosePerPeriod</b>: 1/3 week<span style="background: LightGoldenRodYellow"> (Details: UCUM code wk = 'wk')</span></p></blockquote></div>
  </text>
  <extension
             url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-treatment-intent">
    <valueCodeableConcept>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="373808002"/>
        <display value="Curative - procedure intent (qualifier value)"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <status value="active"/>
  <intent value="order"/>
  <category>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/medicationrequest-category"/>
      <code value="outpatient"/>
    </coding>
  </category>
  <medicationCodeableConcept>
    <coding>
      <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
      <code value="3639"/>
      <display value="DOXOrubicin"/>
    </coding>
  </medicationCodeableConcept>
  <subject>🔗 
    <reference value="Patient/PatientPersona2"/>
  </subject>
  <authoredOn value="2020-10-06"/>
  <requester>🔗 
    <reference value="Practitioner/us-core-practitioner-owen-oncologist"/>
  </requester>
  <reasonReference>🔗 
    <reference value="Condition/primary-cancer-condition-persona-2"/>
  </reasonReference>
  <dosageInstruction>
    <text value="doxorubicin (60 mg/m² IV)"/>
    <timing>
      <repeat>
        <boundsPeriod>
          <start value="2018-04-01"/>
        </boundsPeriod>
      </repeat>
    </timing>
    <route>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="47625008"/>
        <display value="Intravenous route (qualifier value)"/>
      </coding>
    </route>
    <doseAndRate>
      <rateQuantity>
        <value value="60"/>
        <unit value="mg/m2"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="mg/m2"/>
      </rateQuantity>
    </doseAndRate>
    <maxDosePerPeriod>
      <numerator>
        <value value="1"/>
      </numerator>
      <denominator>
        <value value="3"/>
        <unit value="week"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="wk"/>
      </denominator>
    </maxDosePerPeriod>
  </dosageInstruction>
</MedicationRequest>